|
|
|
Volumn 25, Issue 4 SUPPL. 10, 1998, Pages 86-92
|
|
Ameliorating anthracycline cardiotoxicity in children with cancer: Clinical trials with dexrazoxane
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
MESNA;
RAZOXANE;
VINCRISTINE;
ANTINEOPLASTIC ACTIVITY;
CARDIOTOXICITY;
CHILD;
CHILDHOOD CANCER;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FOLLOW UP;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INCIDENCE;
META ANALYSIS;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SARCOMA;
ANTHRACYCLINES;
ANTINEOPLASTIC AGENTS;
CARDIOVASCULAR AGENTS;
CHILD;
CLINICAL TRIALS;
HEART DISEASES;
HUMANS;
RAZOXANE;
|
|
EID: 0031711491
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (36)
|
|
References (42)
|
